Shiraki, Masataka
Kashiwabara, Shoji
Imai, Takumi
Tanaka, Shiro
Saito, Mitsuru
Article History
Received: 5 April 2019
Accepted: 3 June 2019
First Online: 18 June 2019
Change Date: 19 November 2019
Change Type: Correction
Change Date: 19 November 2019
Change Type: Correction
Change Details: In the original publication of the article, the following sentence under the abstract section was published incorrectly as “A multivariable logistic regression analysis revealed that urinary pentosidine was significantly associated with the prevalence of fracture after adjustment for known risk factors for fracture (odds ratio 1.92, 95% CI 1.09–3.37, <Emphasis Type="Italic">P </Emphasis>= 0.023).”
Change Details: In the original publication of the article, the following sentence under the abstract section was published incorrectly as ���A multivariable logistic regression analysis revealed that urinary pentosidine was significantly associated with the prevalence of fracture after adjustment for known risk factors for fracture (odds ratio 1.92, 95% CI 1.09���3.37,P���=���0.023).���
Compliance with ethical standards
:
: MS received consultant fee from Teijin pharma and Asahi Kasei Pharma, a manufacturer of drugs to treat osteoporosis. SK is an employee of SB Bioscience Co., Ltd. TI, ST, and MiS declare no conflicts of interest in association with the present study.